Merck & Co »

Miragen Therapeutics shares owned by Merck & Co

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Merck & Co from 13F filings

Historical chart of Merck & Co investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Merck & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Merck & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.0M 93k 21.58
2025-06-30 $1.3M 93k 13.98